Yearly Archives: 2016

/2016

“LET’S TALK ABOUT NETs”

Media Advisory “LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare [...]

By | 2018-05-07T18:28:12+00:00 October 27th, 2016|Awareness, News|Comments Off on “LET’S TALK ABOUT NETs”

ESMO 2016 NET News

Clinical benefit demonstrated with everolimus and pasireotide LAR alone or in combination in the first randomised, prospective study entirely dedicated to advanced lung and thymic carcinoids. In patients with advanced [...]

By | 2018-05-07T18:28:12+00:00 October 13th, 2016|Clinical Trial, News, Treatment News|Comments Off on ESMO 2016 NET News

2016 Maureen Coleman Award – We Need Your Submissions!

One way that CNETS Canada honours those individuals who have made an outstanding commitment and contribution to the NET cancer patient community is through our annual Maureen Coleman award. Maureen [...]

By | 2018-05-07T18:28:12+00:00 September 23rd, 2016|News|Comments Off on 2016 Maureen Coleman Award – We Need Your Submissions!

First Global Neuroendocrine Tumor Patient Survey Results

“Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs” – a collaborative effort between the International Neuroendocrine Cancer Alliance (INCA) and [...]

By | 2018-05-07T18:28:13+00:00 June 22nd, 2016|News|Comments Off on First Global Neuroendocrine Tumor Patient Survey Results

CNETS Canada Launches NEW WEBSITE

Over the last several years CNETS Canada has worked hard to continuously improve our website and the information contained in it to ensure that it is highly functional and as [...]

By | 2018-05-07T18:28:13+00:00 June 7th, 2016|News|Comments Off on CNETS Canada Launches NEW WEBSITE